Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
about
Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved IssuesEffect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residenceEffect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplantEffect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.Improved survival after acute graft-versus-host disease diagnosis in the modern era.Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.Outcome of transplantation for myelofibrosis.Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.Polymorphisms in the base excision repair pathway and graft-versus-host disease.Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseObesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adultsThe effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomesSecond solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioningHematopoietic stem cell transplantation-50 years of evolution and future perspectives.Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia.Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children.Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent eraManaging high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohortComparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseExtracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study
P2860
Q26750671-3446487E-9709-4E65-B8F3-51C3AEAEEC1EQ30408294-A9755CA0-4A1F-469B-A64A-4C0678A8F0EDQ33605181-722C142B-E00F-498E-B081-23FC9A616CAEQ33653411-237B3F37-BC9A-4FBF-A3A5-22F6A2F9F9D4Q33697246-BC505D17-38B9-4EB4-9A16-6448CF6DBC83Q33706393-ED87C5E2-D422-4398-88AD-6A76CF283DB6Q33718837-7198B8AD-2783-4F84-8AB9-5BB1793B79C6Q33756719-F3DC9EBD-A663-4F34-8244-ACDF902473FBQ33766616-29D2B569-6FD2-4A20-84F2-7136B27E3972Q33783183-EEFFFE9E-A7A3-412D-AB11-882981938E0AQ33813439-BB6B137C-2EB6-4FAE-8465-E05FC346C799Q33816027-39CBDC29-7784-4BE1-8CFD-B36F41CA3902Q33956045-0DCEF74D-9A55-4F43-A981-EC0227D7AB21Q34009595-51619428-523E-4D6F-BB0F-88E9E9EDB10EQ34015474-3953E420-3CCC-4111-BD66-5CA29E7385DCQ34049208-1D250515-93FB-4D7B-AF6F-EE9D9D17C120Q34063337-964DC5B3-C19A-4F9E-A20E-C059784CED48Q34087133-640274E2-C53E-4C6A-A8B8-3F4CE6C5DF3AQ34106444-192418D3-D34E-47AB-9265-72DAB42F7F80Q34187249-05B78336-50F0-47B6-A23F-86C7D6F9C6ABQ34325244-D711EBF8-DA26-4F61-94BD-9DC2583A62E3Q34463419-EF7F1FA1-1BB4-4606-9FBA-8C7F67BAD6D5Q34561032-BC4554EB-1D80-414C-98BC-348A4A78E076Q34620456-438AFB15-EE9E-4F42-8843-7F52469CD93EQ34729272-2A09D691-EF56-45BB-B266-9D9B241A7672Q34743469-1BD4BCCC-A177-4470-90F3-56A5C5535A18Q34749365-B20EA421-E4B1-4894-BACB-AB2577F921C9Q34769213-FD9EDD45-0BDD-4A87-B07D-7339EA984407Q35023409-2D177BCF-8948-46CF-99C9-AD5F8F09869FQ35061893-DC7C94D6-21B7-4434-BA9E-017DE90F48D1Q35067642-F74ACA2E-70B1-4F95-891A-28D2F9FAEB4EQ35078368-A9FA7FFE-F20F-4EE3-9082-26BE3A3FE22DQ35085078-6B0C9E7E-8073-4970-9700-A8BCE7BD4CD1Q35085209-47F89303-5333-498C-BBA6-F490E0FD0871Q35177449-578AF09D-9407-4729-A72C-BC29A5540FE8Q35202316-45074B2A-4885-49F9-838C-05E30CE2BBBDQ35485880-7E6A2FF4-F583-435B-9AA7-B18BE29106C6Q35495340-EA466B0E-C6DD-4E7C-9D68-203E89E9F779Q35542959-D30B7B35-5FFF-4E43-93E9-B4095F2EE8DBQ35574597-0F8424C9-7CD5-4598-9630-91F2ECBC4B91
P2860
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Classification of HLA-matching ...... finitions to predict survival.
@en
Classification of HLA-matching ...... finitions to predict survival.
@nl
type
label
Classification of HLA-matching ...... finitions to predict survival.
@en
Classification of HLA-matching ...... finitions to predict survival.
@nl
prefLabel
Classification of HLA-matching ...... finitions to predict survival.
@en
Classification of HLA-matching ...... finitions to predict survival.
@nl
P2093
P2860
P1476
Classification of HLA-matching ...... finitions to predict survival.
@en
P2093
Claudio Anasetti
Daniel Weisdorf
Dennis Confer
John Klein
Mary Horowitz
Michael Haagenson
Michelle Setterholm
Rebecca Drexler
Roberta King
Stephen Spellman
P2860
P304
P356
10.1016/J.BBMT.2008.04.003
P577
2008-07-01T00:00:00Z